Skip to main content

Table 2 Changes in disease activity, hospitalizations and steroid dosing pre and post transfer.

From: The challenges of transferring chronic illness patients to adult care: reflections from pediatric and adult rheumatology at a US academic center

Disease Activity Pre-Transfer Post-Transfer P value
Median (range) SLEDAI score* 4 (0–16) 4 (0–20) 0.3
Disease activity**    
   None 12 (80) 10 (67)  
   Mild/moderate 2 (13) 4 (27) 0.16
   Severe 1 (7) 1 (7)  
Number of Hospitalizations*    
Total 32 6 0.017
   Scheduled 21 2 0.03
   Flare associated 8 4 0.26
Steroid Dosing    
Median prednisone dose at last visit, mg (range) 5 (0–40) 2 (0–20) 0.004
Median peak prednisone dose, mg (range) 10 (0–60) 5 (0–60) 0.059
IV methylprednisolone, No (%) 3 (10) 4 (13) 0.99
  1. * Systemic Lupus Erythematosus (n = 16)
  2. **MCTD, APLS, Vasculitis, Spondylarthropathy (n = 15)
  3. IV = Intravenous
\